T. Rowe Price Investment Management

Activity in this selectionsutter-hill-ventures-207ec04c

By stage

Series B2

Series C+2

Biotech3

Hardware1

United States4

4 in this selection

Jun 24

Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD

$330MSeries B

Role not disclosed

Apr 9

Develops RISC-V processor IP for customizable and energy-efficient computing solutions

$400MSeries G

Role not disclosed

Jan 28

Develops automated cell therapy manufacturing platforms

$257MSeries D

Role not disclosed

Jan 12

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

$250MSeries B

Role not disclosed